TipRanks
Go Ultimate55% OFF

Oncolys BioPharma, Inc. (4588) Balance Sheet

Oncolys BioPharma, Inc. Balance Sheet

Oncolys BioPharma, Inc.'s total assets for Q4 2025 were $4.56B, an increase of 108.18% from the previous quarter. JP:4588 total liabilities were $555.91M for the fiscal quarter, a 33.13% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 4.56B$ 3.20B$ 2.04B$ 2.65B$ 4.29B
$ 555.91M$ 446.65M$ 566.50M$ 491.69M$ 697.88M
$ 4.00B$ 2.75B$ 1.47B$ 2.16B$ 3.59B

Currency in JPY

Oncolys BioPharma, Inc. Debt to Assets

02B4B6B8 %16 %24 %32 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets